Northern Trust Corp Tango Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 479,250 shares of TNGX stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

479,250

Previous 391,576 22.39%

Holding current value

$1.46 Million

Previous $3.36 Million 9.85%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.36 - $11.93 $645,280 - $1.05 Million	87,674 Added 22.39%	479,250 $3.69 Million
Q2 2024 Aug 14, 2024	SELL	$6.66 - $10.15 $63,622 - $96,962	-9,553 Reduced 2.38%	391,576 $3.36 Million
Q1 2024 May 14, 2024	SELL	$7.51 - $12.88 $84,675 - $145,222	-11,275 Reduced 2.73%	401,129 $3.18 Million
Q4 2023 Feb 13, 2024	BUY	$6.52 - $12.01 $71,478 - $131,665	10,963 Added 2.73%	412,404 $4.08 Million
Q3 2023 Nov 13, 2023	BUY	$2.93 - $11.26 $43,788 - $168,280	14,945 Added 3.87%	401,441 $4.52 Million
Q2 2023 Aug 11, 2023	SELL	$2.67 - $4.7 $32,034 - $56,390	-11,998 Reduced 3.01%	386,496 $1.28 Million
Q1 2023 May 15, 2023	SELL	$3.76 - $8.06 $38,498 - $82,526	-10,239 Reduced 2.51%	398,494 $1.57 Million
Q4 2022 Feb 13, 2023	SELL	$3.41 - $8.29 $27,406 - $66,626	-8,037 Reduced 1.93%	408,733 $2.96 Million
Q3 2022 Nov 14, 2022	SELL	$3.25 - $5.46 $61,113 - $102,669	-18,804 Reduced 4.32%	416,770 $1.51 Million
Q2 2022 Aug 12, 2022	BUY	$3.86 - $8.01 $1.21 Million - $2.52 Million	314,019 Added 258.33%	435,574 $1.97 Million
Q1 2022 May 13, 2022	SELL	$7.01 - $10.94 $21,065 - $32,874	-3,005 Reduced 2.41%	121,555 $921,000
Q4 2021 Feb 08, 2022	BUY	$9.55 - $14.29 $108,965 - $163,048	11,410 Added 10.08%	124,560 $1.36 Million
Q3 2021 Nov 15, 2021	BUY	$9.56 - $17.3 $1.08 Million - $1.96 Million	113,150 New	113,150 $1.46 Million

Others Institutions Holding TNGX

# of Institutions

123

Shares Held

91.7M

Call Options Held

3.1K

Put Options Held

1.5K

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $268M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Tango Therapeutics, Inc. Transaction History